Position in PRGO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,198,944
-$10,514,324 QoQ
Shares Held
1,559,090
-37.3% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 334 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Sep 30, 2025CallValue
$445,400
CallShares
20,000
PutValue
$445,400
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,366 across 82 Drug Manufacturers - Specialty & Generic names. PRGO ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in PRGO
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,198,944 | 1,559,090 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $26,713,268 | 2,487,269 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $21,734,033 | 1,561,353 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $33,925,917 | 1,523,391 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $445,400 | 20,000 | Call | Defined | 2025-11-13 | |
| 2025-09-30 | $445,400 | 20,000 | Put | Defined | 2025-11-13 | |
| 2025-06-30 | $17,821,865 | 666,986 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,148,002 | 504,565 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,424,247 | 405,455 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $1,025,829 | 39,900 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $15,172,689 | 578,448 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,698,290 | 650,245 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $289,710 | 9,000 | Call | Defined | 2024-05-13 | |
| 2024-03-31 | $19,526,357 | 606,597 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,968,842 | 340,859 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $289,620 | 9,000 | Call | Defined | 2024-02-09 | |
| 2023-09-30 | $2,476,125 | 77,500 | Put | Defined | 2023-11-09 | |
| 2023-09-30 | $14,262,447 | 446,399 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $6,831,147 | 201,212 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,153,805 | 199,437 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,507,746 | 190,899 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $424,211 | 11,896 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $557,350 | 13,738 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $380,187 | 9,893 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $576,652 | 14,824 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,670,749 | 35,300 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $502,596 | 10,619 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,841,255 | 105,589 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,618,220 | 89,405 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $9,016,758 | 201,627 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,115,692 | 89,647 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $17,809,430 | 322,226 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,607,311 | 33,423 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||